CHEMED CORPORATION (CHE)

Healthcare · Services-Home Health Care Services · Price $523.38
Updated: Aug 30, 2026
Gross Profit (TTM)
$859.3M
Trailing 12 Months
Growth Rate
3.96%
Log-Linear Regression (16Q)
Gross Margin
33.11%
Pricing Power
Revenue
$2.6B
Top Line Sales
Operating Income
$349.2M
After OpEx

📈 Gross Profit History (16 Quarters)

🧮 CHE Gross Profit Breakdown

Gross Profit = Revenue - Cost of Revenue
Revenue (Total Sales) $2.6B
Less: Cost of Revenue (COGS) $1.7B
Equals: Gross Profit $859.3M

Understanding Gross Profit

Gross Profit is Revenue minus Cost of Revenue (also called Cost of Goods Sold or COGS). It measures how much a company earns from selling its products before subtracting operating expenses. For CHE, the trailing twelve month gross profit is $859.3M.

Why Gross Profit Matters

Gross margin (Gross Profit / Revenue) is one of the most important indicators of pricing power and competitive advantage. Companies with high and stable gross margins typically have differentiated products, strong brands, or unique capabilities.

CHE's gross profit growth rate of 3.96% (based on log-linear regression of 16 quarters) indicates modest positive growth in gross profit.

Gross Margin: The Key Metric

CHE's gross margin of 33.11% shows what percentage of each sales dollar remains after paying direct production costs. Gross margins between 25-40% are common in competitive manufacturing and retail businesses.

Gross Profit vs Other Profitability Metrics

Operating Income: $349.2M →

Gross Profit minus operating expenses (SG&A, R&D). Shows profitability after all operating costs but before interest and taxes.

Net Income: $275.0M →

The bottom line after all expenses including interest and taxes. The final measure of accounting profit.

Free Cash Flow: $377.1M →

Actual cash generated after capital expenditures. Can differ significantly from gross profit due to working capital and capex.

Revenue: $2.6B →

The top line that gross profit is derived from. Gross margin shows what percentage becomes gross profit.

Summary: CHE Gross Profit Trend

CHEMED CORPORATION (CHE) has a gross margin of 33.11%, which Zyberno classifies as acceptable for a Healthcare company — within the 20–40% range Zyberno considers typical for healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 3.96% annually — positive but below the 10% level Zyberno considers strong growth. For complete financial analysis, view the full CHE stock report on Zyberno.

Frequently Asked Questions

What is CHE's current gross profit?

CHEMED CORPORATION's trailing twelve month (TTM) gross profit is $859.3M, growing at 3.96% annually — positive but below the 10% level Zyberno considers strong growth.

Is CHE's gross profit growing?

CHEMED CORPORATION (CHE) has a gross margin of 33.11%, which Zyberno classifies as acceptable for a Healthcare company — within the 20–40% range Zyberno considers typical for healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 3.96% annually — positive but below the 10% level Zyberno considers strong growth.

What is CHE's gross margin?

CHEMED CORPORATION (CHE) has a gross margin of 33.11%, which Zyberno classifies as acceptable for a Healthcare company — within the 20–40% range Zyberno considers typical for healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 3.96% annually — positive but below the 10% level Zyberno considers strong growth.

What is the difference between gross profit and net income?

Gross profit is Revenue minus Cost of Revenue only. Net income also subtracts operating expenses, interest, and taxes. CHE's gross profit is $859.3M versus net income of $275.0M.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
$753.07
🛡️
Margin of Safety
Valuation Gap
30.5%
🎯
Expected Return
Projected Annual
25.0%
Click any metric for full methodology and detailed analysis

📊 Full CHE Stock Report

See CHE's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 CHE Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 CHE Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 CHE Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 CHE Earnings Surprise (SUE)

See whether CHE is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 CHE Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 CHE Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 CHE Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 CHE Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full CHE Report Find More Quality Stocks
Scroll to Top